Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 29.60 29.00 30.20 29.60 29.60 29.60 53,210 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.6 -1.2 - 46

Skinbiotherapeutics Share Discussion Threads

Showing 7576 to 7599 of 8575 messages
Chat Pages: Latest  307  306  305  304  303  302  301  300  299  298  297  296  Older
DateSubjectAuthorDiscuss
10/9/2020
11:09
Elric has done a number of detailed Interviews investors can make their own Mind up
atlantic57
10/9/2020
10:59
Trouble is, nothing is fundermentally any good without some verification on the effective front. And I get a feeling, that Croda are setting up a production line just for sbtx...maybe because they have been asked, as sbtx doesn’t have that ability? Ie, sub-contracting. Don’t listen to elrico, he’s inclined to bs on behalf of his contacts?
rayrac
10/9/2020
10:39
Agreed and I am holding quite a few shares here already. Not selling any either.
rafboy
10/9/2020
10:25
No rhyme or reason to it either. Nothing has fundamentally changed to my knowledge. In fact at these levels it is worth a top up as when that trial kicks off in Q1 next year this stock will be hard to get as it always is when on the rise.
madaboutmed
10/9/2020
10:17
Blimey heading south again. Be nice to stay above 20p at the very least but not today it seems.
rafboy
10/9/2020
08:16
From a business point of view, this makes perfect sense because it not only allows the form CEO. Cath O'Neil more time in the labs, along with other lab geeks exorcising their creative genius for the future. SkinBiotherapeutics CEO. Stuart Ashman commented to me: "Jonathan brings a much needed clinical experience to advance our MediBiotix. Jonathan also adds a wealth of connections in the clinical research field that will assist us with the various clinical trial we need to execute over the next few years." https://lemminginvestors.blogspot.com/2020/09/skinbiotherapeutics-adds-senior-medial.html?m=1
elrico
09/9/2020
14:15
rayrac et al, probably worth listening to the Shareprophets presemtation on the Skinbio website again. There it is made clear that the Croda deal, where the spend by Croda on the £5m dedicated skin biotix production line, which cannot be used for any other product, was viewed by Skinbio as the equivalent to receiving an upfront milestone payment. Why? Because the deal included the option for Skinbio to buy back the end product at near cost price and sell it direct if they so desire. In practice, the royalties of a successful anti ageing product are likely to be in the realm of £250M using matrixyl as a guideline with the additional spinoff that it will accelerate the route to market for Pharma Biotix. In terms of will it work; well don't forget that the reason for Croda interest was that the impact on the elastic fibres in the skin was found by accident when analysing the safety data tests; so I would suggest it is is very unlikely that it will disappoint.
aquaesulis01
09/9/2020
11:05
I do my best.😇
rayrac
09/9/2020
10:50
RayracI am obviously aware of your history with opti and here. To be honest you have been filtered for years but for some reason I decided to look at your post here and respond. It's obvious we will never agree so I will discontinue this nowI am not sure that croda investing 5m to get to production is giving it to them on a plate. Double digit royalties will follow and I am happy for that to follow. Although it's quite clear from your post that Stuart should have got you to do the negotiating with croda as you obviously you would have negotiated much better terms so maybe you can suggest that to him for the next deal. I realise that you are only here out of the goodness of your heart to save investors their wealth and I think that is jolly noble of you. There is only another few hundred companies on Aim for you to provide the same service
gary hindsight
09/9/2020
10:27
So Ray when I say -Now how do you develop things, let?s get a time served expert and go to trials. At what point am I suggesting it's not requiring trials? Seems we agree but for some reason you want us not too? The guy has been employed, I think it's potentially a good thing and you think they should wait until the product is shelf ready.
trumpingtonsmythe
09/9/2020
10:14
Oh, so it’s been handed on a plate to Croda without any benefit too sbtx?! Other than royalties when it starts production...which isn’t in sight as we speak! Come on, pull the other. Surely the ip is worth more than just potential royalties?! And Croda are the only interested party...so we are informed? Quite honestly, I don’t think Croda will touch it without proof of concept.
rayrac
09/9/2020
09:38
raytard what do you know lol quote raytard there is no way this lpldl can get rid of eczema lol no ray its for cholesterol wooooooooooooooooow tell us about the rabbits ray
manc10
09/9/2020
09:35
Well according to ceo they have managed to replicate the lysate production and effects already at sederma. So as far as I can see the effectiveness that impressed them enough to sign a deal is replicable. The time frames for full production have been telegraphed from the beginning and in fact are ahead of schedule so not having a full production scale yet is already known so I am not sure why that's in questionUpfront payment ? Not sure why you even mention that. It wasn't part of the royalty agreement so there was no expectation of one so why are you saying where is it?
gary hindsight
09/9/2020
09:28
Is there a product off the ‘production line’ yet? And where are the up-front fees to Opti?!
rayrac
09/9/2020
09:15
You say sure they will look at it. Don't you think they did that before investing 5m in the production line? You think they did that without having a clue of the benefits over matrixyl? Let's spend 5m and see what happens ?
gary hindsight
09/9/2020
09:06
Croda? They are sure to look at it. But it amounts to the same thing...got to be proven.
rayrac
09/9/2020
08:59
Ok maybe we should make sure we are talking about the same thing first. If you are talking about the psoriasis treatment I agree with you it's not proven yet. If you are talking about the sbtx for croda I don't agree with youCan we agree on that ?
gary hindsight
09/9/2020
08:40
Btw Gary, it’s unproven.
rayrac
09/9/2020
08:38
I’m just saying the tech is unproven Trump...hence the trials Stop trying to suggest otherwise!
rayrac
09/9/2020
08:31
RayYou say that science yet to be proved yet it's been confirmed that sederma saw the same results from their newly commissioned production line that sbtx saw in development. Doesn't suggest the science was a fluke and also suggests croda saw the commercial benefit of sbtx when signing the deal in the first place. Which bit of that says it's unproven
gary hindsight
09/9/2020
08:06
Thanks Ray, yes when the product is developed the price will rise. Now how do you develop things, let's get a time served expert and go to trials. Are you suggesting you know the trials have failed, that would be insider info?
trumpingtonsmythe
09/9/2020
08:03
The Advfn bb are very amusing. When a share is rising ,the board is full of posters telling you how high it will go. When it starts falling Suddenly the doom and gloom posters emerge. As far as I am aware there have been no changes in the company position. However there have no news announcements and of course market conditions have changed.
atlantic57
09/9/2020
07:17
TrumpingtonSmythe8 Sep '20 - 07:41 - 6560 of 6569 0 3 0 Or ‘CEO of the Clinical Research Network for 10 years, he has the expertise and extensive network in clinical research that will be of critical importance to the Company as we progress our product development programmes.’ Is adding to the area where strength is needed, the tech is fine it’s the development knowledge that’s needed? The tech is unproven, otherwise the share price would be far higher!? Pied piper at play
rayrac
08/9/2020
17:20
Don't worry, almost 3 years even if the employ you to do some PR. Clown.
slartybartfaster
Chat Pages: Latest  307  306  305  304  303  302  301  300  299  298  297  296  Older
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210119 08:33:07